Multi-centred Clinico-genetic Study of Actinic Prurigo in Thailand

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

47 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-30

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research project investigates the clinical and genetic associations of Actinic Prurigo (AP) in the Thai population. As a rare chronic photodermatosis, AP has been observed to occur more frequently in individuals with certain genetic predispositions, particularly specific Human Leukocyte Antigen (HLA) types. Previous studies have suggested variations in clinical presentation and HLA allele distributions between Asian and Western populations.

The primary aim is to explore the relationship between clinical manifestations of AP and genetic profiles, including HLA typing, among Thai individuals. Additionally, the study seeks to examine whether different HLA types are associated with varying responses to treatment.

The study design is a cross-sectional comparative study, involving both AP patients and age-matched healthy controls. Given the rarity of the condition, patient recruitment will be conducted across four collaborating institutions:

King Chulalongkorn Memorial Hospital Siriraj Hospital Institute of Dermatology

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)

NCT01630421

Aplasia Cutis Congenita

RECRUITING

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

NCT01952275

Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue Pyoderma Gangrenosum Erosive Pustular Dermatosis of the Scalp +25 more

UNKNOWN

Identification of Mutations Responsible for Rare Familial Skin Diseases by Next Generation Sequencing

NCT02509650

Familial Lipomatosis Very Rare Dermatologic Diseases

UNKNOWN

Genetic Analysis of Psoriasis and Psoriatic Arthritis

NCT00341809

Psoriasis

COMPLETED

Genetic Determinants of Ankylosing Spondylitis Severity

NCT00056849

Ankylosing Spondylitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Actinic Prurigo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case

Targeted long-read HLA sequencing

Intervention Type DIAGNOSTIC_TEST

Genetic study

RNA extraction

Intervention Type OTHER

Nanostring technology, Seattle

Full Skin examination

Intervention Type OTHER

Skin and mucosa examination

Control

Targeted long-read HLA sequencing

Intervention Type DIAGNOSTIC_TEST

Genetic study

RNA extraction

Intervention Type OTHER

Nanostring technology, Seattle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Targeted long-read HLA sequencing

Genetic study

Intervention Type DIAGNOSTIC_TEST

RNA extraction

Nanostring technology, Seattle

Intervention Type OTHER

Full Skin examination

Skin and mucosa examination

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Short-read whole genome sequencing

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Thai ethnicity
* Diagnosed with Actinic Prurigo (AP) according to the diagnostic criteria defined for this study
* Mentally competent, able to communicate, and able to read Thai.
* Participants receiving Thalidomide treatment must use two simultaneous methods of contraception, starting at least 4 weeks prior to initiating the medication and continuing throughout the treatment period and for at least 4 weeks after discontinuation.

Exclusion Criteria

* History and physical examination findings suggestive of other photodermatoses such as Lupus erythematosus, Porphyria, or Polymorphous Light Eruption, among others.
* Elevated Epstein-Barr Virus (EBV) viral load detected in blood testing (EBV viral load will be tested in all participants).
* Low Minimal Erythema Dose (MED) to UVB radiation as the only abnormal finding.

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes